Healthcare -
Biotechnology - NASDAQ - US
$ 11.87
-0.785 %
$ 172 M
Market Cap
0.1
P/E
INBX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities INBX - Inhibrx Biosciences, Inc.
71.7 M
LAST VALUE
-47.35%
2 YEAR CAGR
10.59%
5 YEAR CAGR
0.00%
10 YEAR CAGR